Showing results (171-180 of 302) with videos related to

Sort By:
Pageof 31
Respiratory Investigation|October 15, 2024
Pulmonary fibrosis in pulmonary alveolar proteinosis evaluated by transbronchial lung cryobiopsy: A single-center retrospective studyKensuke Kanaoka, Toru Arai, Takayuki Takimoto, et al.
Respiratory Medicine Case Reports|December 15, 2020
Lymphoplasmacytic lymphoma involving the mediastinum and the lung, followed by amyloidosis: A surgically and genetically proven caseYuichi Adachi, Takayuki Takimoto, Maiko Takeda, et al.
Respiratory Investigation|December 7, 2021
Expectations of respiratory physicians from psychologists in palliative care for patients with non-cancer respiratory diseasesYoshinobu Matsuda, Takako Kosugi, Masako Yamanaka, et al.
European Journal of Radiology|September 23, 2015
Diagnostic certainty of idiopathic pulmonary fibrosis/usual interstitial pneumonia: The effect of the integrated clinico-radiological assessmentJunya Tominaga, Fumikazu Sakai, Takeshi Johkoh, et al.
The European Respiratory Journal|June 1, 2023
Treatable traits: a comprehensive precision medicine approach in interstitial lung diseaseYet H Khor, Vincent Cottin, Anne E Holland, et al.
Respiratory Research|October 30, 2022
End-of-life care for idiopathic pulmonary fibrosis patients with acute exacerbationNorimichi Akiyama, Tomoyuki Fujisawa, Tatsuya Morita, et al.
Respirology (Carlton, Vic.)|March 22, 2023
Palliative care for interstitial lung disease: A nationwide survey of pulmonary specialistsTomoyuki Fujisawa, Norimichi Akiyama, Tatsuya Morita, et al.
Nature Communications|June 26, 2026
Affinity- and epitope-dependent pathogenicity of GM-CSF autoantibodies in patients with autoimmune pulmonary alveolar proteinosisShinji Futami, Chie Kawai, Jun-Ichi Kishikawa, et al.
BMJ Supportive & Palliative Care|November 17, 2019
Morphine for dyspnoea in chronic obstructive pulmonary disease: a before-after efficacy studyYoshinobu Matsuda, Tatsuya Morita, Hirotaka Matsumoto, et al.
Respirology (Carlton, Vic.)|January 15, 2023
Nintedanib in Asian patients with progressive fibrosing interstitial lung diseases: Results from the INBUILD trialYoshikazu Inoue, Athol U Wells, Jin Woo Song, et al.
Pageof 31